The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
HYEX · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | HYEX | COLL | NAGE | BSX |
|---|---|---|---|---|
| Moat Score (0–100) | 60 (highest) | 60 (highest) | 60 (highest) | 60 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 54 | 76 (highest) | 76 (highest) | 66 |
| Pricing power | 63 | 67 | 91 | 100 (highest) |
| Returns on capital | — | 100 (highest) | 8 | 6 |
| Balance-sheet safety | 78 | 28 | 100 (highest) | 50 |
| Capital discipline | 44 | 28 | 24 | 75 (highest) |
| Price vs. high estimate | No price data | 68% below high estimate | No price data | No price data |
| Market cap | $16.9M | $1.1B | $268.6M | — |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |